IFNA2 and acute myeloid leukemia: Numerous studies have suggested that IFN-α could play a role in inducing anti-leukemic responses in vivo (20); however, only single case reports or studies with small sample sizes have supported that IFN-α could be a treatment choice for AML (22, 49–51).